Current ABAM applicants holding certification by ABAM must meet the medical licensure and ABMS certification requirements to be considered for the Addiction Medicine subspecialty examination.
The current status of each applicant will be verified through ABAM during the review of their application.
Physicians who have passed the 2015 ABAM examination, and meet the medical licensure and ABMS board certification requirements, must submit formal application through the “ABAM Diplomate” Pathway. Once reviewed and approved by the Board, the applicant’s exam requirement may be waived. Certification will be conferred following usual procedures, with an effective date of January 1, 2018.
All ABAM certificants will be required to apply for and take the examination, with one exception.
For individuals who passed the 2015 ABAM examination and who, upon review of their application, meet all ABPM requirements, the examination will be waived and certification will be conferred following usual procedures, with an effective date of January 1st of 2018 for applicants in 2017. This waiver applies only to individuals who passed the 2015 ABAM examination and who meet the other eligibility requirements.
If applying through the Practice Pathway: No
If applying through the ABAM Pathway: Yes
It is the responsibility of the applicant to determine their currency status.
The ABAM pathway will be available through the 2021 application cycle. The Addiction Medicine subspecialty certifying exam will be given annually throughout this period.
Time spent working as the primary decision-maker providing direct patient care in the specialty practice of Addiction Medicine counts toward the Practice Pathway. Practice Pathway settings may include: office-based opioid treatment program prescribing buprenorphine; working in a methadone maintenance clinic, providing medically managed withdrawal treatment from alcohol, sedatives, opioids, or other substances; hospital-based addiction consultation services (consultation-liaison service); medical director of a residential addiction treatment program and other settings
Non-compensated or volunteer work will count towards the total required practice time, as long as the candidate is functioning as the primary decision maker providing direct patient care. Time spent just observing (shadowing) without primary decision making responsibility for patient care does not count towards the 1920 hours. These activities must be verified with appropriate documentation/letters of support.
Addiction Medicine practice outside of direct patient care including research and/or administration and/or teaching activities – may count for a combined maximum of 75% (or 1440 hours) of the total required minimum practice time of 1920 hours. Documentation of work in these areas will require submission of product or independent verification of activity, such as: published paper, list of lectures, etc. Applicants must demonstrate a minimum of 25% (or 480 hours) as “Direct Patient Care”.
An applicant may count up to 25% of a general practice (e.g., FM, IM, EM, etc) with a general statement that this proportion of their practice is treating addicted patients. This 25% applies to the 1920 hours in total (480 hrs), not 480 hours each year. You cannot meet the total requirements in general practice. An applicant may offer an additional percentage of their practice as an addiction medicine practice, but the documentation of that practice would be the responsibility of the applicant and subject to verification and acceptance by the Board. An applicant must have 75% (1440 hours) documented in the specialty practice of Addiction Medicine (as patient care, administration, research, and/or teaching) separate from general practice.
No, observation or “shadowing”—even in the specialty of Addiction Medicine—without “hands-on” patient care for which you are the primary provider, does not count towards fulfilling the requirements for the Practice Pathway. An observership without being responsible for the direct care of the patient as the attending physician is similar to being a trainee. Only direct patient care specifically in Addiction Medicine for which you are the primary provider counts towards the 1920 hours required for the Practice Pathway.
ABPM does not provide credit for any time spent in a residency. Electives may not count towards the practice path.
Report the number of hours spent during that month in direct patient care, administration, or research during this experience.
ABPM does not provide credit for any time spent in non-addiction medicine fellowships. Electives may not count towards the practice pathway
While the ABPM supports the commitment to lifelong learning embodied in CME/MOC activities, initial subspecialty certification through the ABPM requires no CME/MOC documentation. CME credit—even in the specialty of Addiction Medicine—does not count towards fulfilling the requirements for the Practice Pathway. The required 1920 hours may only consist of direct patient care, specifically in Addiction Medicine.
No, the letter for documentation and verification of Addiction Medicine Practice for the Practice Pathway cannot be written by a practice partner, even one certified in Addiction Medicine. The verification letter must come from an independent supervising physician, such as a Chief of Staff, Department Chair, or Fellowship Director. If there is no independent supervising physician that meets these criteria, then the applicant must provide documentation for consideration by ABPM the credentials of the individual who will provide the letter of verification for the applicant. The ABPM will make the final determination of the suitability of the individual providing the letter of verification.
Up to 25% of the time spent in a General Practice (whether in Psychiatry, Internal medicine, Family Medicine, Pediatrics, etc.) can be counted towards the required 1920 hours spent in the practice of Addiction Medicine. In the example above, only 12 hours per week (25% of 48 hours/week) would count towards the Practice Pathway.
CME credit even in the specialty of Addiction Medicine does not count towards fulfilling the requirements for the Practice Pathway. The required 1920 hours may only consist of direct patient care, research, training and administration specifically in Addiction Medicine.
An Addiction Psychiatry fellowship does not meet the ADM fellowship requirements. The time could logically be applied to the practice track requirements.
Certification through the AOA/Canada will not fulfill the board requirements for subspecialty certification through the ABPM. Requirements state physicians must hold current primary certification through 1 of the 24 member boards of ABMS. The 24 member boards can be found listed here: http://www.abms.org/member-boards/
You can register by visiting our website at http://theabpm.org/ and hitting the “register now” button. There are two different pathways for addiction medicine. If you are an ABAM diplomate, you would take the ABAM Diplomate Pathway. If not, you would apply through the Practice Pathway. All requirements and additional information on the pathways can be found here: http://theabpm.org/images/docs/AddictionMedicine.pdf.
Primary board certification is a core requirement. Some ABMS boards accept subspecialty certification as meeting the primary certification requirements. In those cases the individual would be listed as certified in the primary specialty.
The status of primary certification is determined by each individual board.
A physician who has voluntarily entered into a rehabilitation program for chemical dependency/addiction/substance use disorder or a practice improvement plan with the approval of a state medical board shall not be considered to have a restriction on his/her license to practice medicine for the purposes of applying to ABPM for certification in Addiction Medicine. This would not prevent the physician from applying to ABPM for certification in Addiction Medicine.
The Practice Pathway will be available for the first five years the new subspecialty examination is administered. For Addiction Medicine, the five-year interval is from 2017 through 2021. Beginning in 2022, all applicants for certification in Addiction Medicine must successfully complete an ACGME-accredited Addiction Medicine fellowship program.
Applicants who have completed existing fellowships that are not ACGME accredited will be given consideration by the ABPM through the Practice Pathway. Credit for completion of training in a non-ACGME accredited fellowship program may be substituted for the Practice Time Requirement. The applicant must have successfully completed an Addiction Medicine fellowship of at least 12 months that is acceptable to the American Board of Preventive Medicine. Fellowship training of less than 12 months may be applied towards the Time in Practice hour requirements of the Practice Pathway. The fellowship training curriculum as well as a description of the actual training experience must also be submitted for final approval by the Board.
The Accreditation Council for Graduate Medical Education (ACGME) has approved the accreditation of fellowships in the subspecialty of Addiction Medicine. The specific requirements for the ACGME-accredited fellowships in Addiction Medicine are currently under development. Institutions seeking ACGME accreditation for Addiction Medicine fellowships should contact the ACGME and follow their requirements. The accreditation process will likely start in early 2018.
October 16 through October 28 at a Prometric testing site. See website for details.
The Addiction Medicine requirements and features of continuous certification are being developed and will likely closely parallel those of other ABPM subspecialties. These include a ten-year certification cycle length, a valid and unrestricted license to practice in all jurisdictions in which one is licensed, lifelong learning in ABPM approved activities, successful participation in a secure examination, and verification of improvement in practice, i.e., the four parts of continuous certification.
There is a $500 Board Review Fee associated with all addiction medicine applications.